Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript
Edwards Lifesciences Corporation beats earnings expectations. Reported EPS is $0.66, expectations were $0.64.
Edwards Lifesciences Corp (EW)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 24,775 | $2,367,499 | +20% | 1.44% |
| 2. | 14,100 | $1,347,396 | +124% | 0.09% | |
| 3. | RiverPark Advisors Mitch Rubin | 13,056 | $1,247,631 | -17% | 1.02% |
| 4. | 10,300 | $984,268 | -18% | 0.07% | |
| 5. | Impax Asset Management Ian Simm | 7,800 | $745,368 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.23 | 1,500 | Director | 63,811 | 2021-11-24 | Filing | |
| $90.10 | 3,000 | Director | 9,042 | 2017-02-03 | Filing | |
| $83.33 | 3,942 | Officer | 3,942 | 2016-11-30 | Filing | |
| $83.47 | 8,928 | Officer | 43,690 | 2016-11-30 | Filing | |
| $84.63 | 3,000 | Director | 6,042 | 2016-11-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.59 | 17,143 | Director | 4,486 | 2024-05-02 | Filing | |
| $85.02 | 12,207 | Director | 21,629 | 2024-05-02 | Filing | |
| $84.11 | 12,240 | Officer | 173,849 | 2024-05-01 | Filing | |
| $84.83 | 2,160 | Officer | 186,089 | 2024-05-01 | Filing | |
| $85.74 | 6,550 | Officer | 19,074 | 2024-04-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 52,362,913 | $3,992,672,117 | 0.08% | |
| 2. | 52,172,777 | $3,978,174,250 | 0.1% | |
| 3. | 26,955,650 | $2,055,368,313 | 0.09% | |
| 4. | 19,088,643 | $1,455,509,029 | 0.56% | |
| 5. | 18,181,420 | $1,386,333,279 | 1.94% |
News See All
14 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Edwards Lifesciences Corporation (NYSE:EW) Q4 2023 Earnings Call Transcript
Edwards Lifesciences Corporation misses on earnings expectations. Reported EPS is $0.609 EPS, expectations were $0.64.
Edwards Lifesciences Corporation (EW) Fell in Q4 Despite Double-Digit Revenue Growth
Wedgewood Partners, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, Inc, released the “Carillon Scout Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
12 Best Medical Technology Stocks To Buy Now
In this article, we discuss 12 of the best medical device stocks to buy now.
Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Edwards Lifesciences Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Edwards Lifesciences Corporation (EW) Declined Despite Double-Digit Revenue Growth
Wedgewood Partners, an investment management company, released its “Wedgewood Partners Large Cap Focused Growth Fund” third quarter 2023 investor letter.
Ken Fisher's Top 15 Healthcare Stock Picks
In this article, we discuss the top 15 healthcare stock picks of Ken Fisher.
Billionaire Hedge Funds
